Structural dataset for the fast-exchanging KRAS G13D

Jia Lu, John Hunter, Anuj Manandhar, Deepak Gurbani, Kenneth D. Westover

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Cancers bearing the KRAS G13D mutation are notable for their distinct clinical behavior relative to other oncogenic KRAS mutations. We hypothesized that primary biochemical or biophysical properties of KRAS G13D might contribute to these clinical observations and as part of our study undertook structural studies using x-ray crystallography. In this data article we discuss several x-ray diffraction datasets that yielded structures of oncogenic KRAS mutants including a high resolution (1.13. Å) structure of KRAS G13D. The datasets are typical for high resolution x-ray diffraction data and allow the construction of atomic resolution, three dimensional structural models with high confidence. This data can be correlated with biochemical information such as defects in substrate binding kinetics, GTPase activities and interactions with the RAS effector RAF kinase.

Original languageEnglish (US)
Pages (from-to)572-578
Number of pages7
JournalData in Brief
Volume5
DOIs
StatePublished - Dec 1 2015

Fingerprint

RAF
structural model
cancer
confidence
interaction

Keywords

  • Cancer
  • GTPase
  • KRAS
  • X-ray crystallography

ASJC Scopus subject areas

  • General
  • Education

Cite this

Structural dataset for the fast-exchanging KRAS G13D. / Lu, Jia; Hunter, John; Manandhar, Anuj; Gurbani, Deepak; Westover, Kenneth D.

In: Data in Brief, Vol. 5, 01.12.2015, p. 572-578.

Research output: Contribution to journalArticle

Lu, Jia ; Hunter, John ; Manandhar, Anuj ; Gurbani, Deepak ; Westover, Kenneth D. / Structural dataset for the fast-exchanging KRAS G13D. In: Data in Brief. 2015 ; Vol. 5. pp. 572-578.
@article{d72cc6131d1845c981cc9a1ff8f3a2b3,
title = "Structural dataset for the fast-exchanging KRAS G13D",
abstract = "Cancers bearing the KRAS G13D mutation are notable for their distinct clinical behavior relative to other oncogenic KRAS mutations. We hypothesized that primary biochemical or biophysical properties of KRAS G13D might contribute to these clinical observations and as part of our study undertook structural studies using x-ray crystallography. In this data article we discuss several x-ray diffraction datasets that yielded structures of oncogenic KRAS mutants including a high resolution (1.13. {\AA}) structure of KRAS G13D. The datasets are typical for high resolution x-ray diffraction data and allow the construction of atomic resolution, three dimensional structural models with high confidence. This data can be correlated with biochemical information such as defects in substrate binding kinetics, GTPase activities and interactions with the RAS effector RAF kinase.",
keywords = "Cancer, GTPase, KRAS, X-ray crystallography",
author = "Jia Lu and John Hunter and Anuj Manandhar and Deepak Gurbani and Westover, {Kenneth D.}",
year = "2015",
month = "12",
day = "1",
doi = "10.1016/j.dib.2015.10.001",
language = "English (US)",
volume = "5",
pages = "572--578",
journal = "Data in Brief",
issn = "2352-3409",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Structural dataset for the fast-exchanging KRAS G13D

AU - Lu, Jia

AU - Hunter, John

AU - Manandhar, Anuj

AU - Gurbani, Deepak

AU - Westover, Kenneth D.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Cancers bearing the KRAS G13D mutation are notable for their distinct clinical behavior relative to other oncogenic KRAS mutations. We hypothesized that primary biochemical or biophysical properties of KRAS G13D might contribute to these clinical observations and as part of our study undertook structural studies using x-ray crystallography. In this data article we discuss several x-ray diffraction datasets that yielded structures of oncogenic KRAS mutants including a high resolution (1.13. Å) structure of KRAS G13D. The datasets are typical for high resolution x-ray diffraction data and allow the construction of atomic resolution, three dimensional structural models with high confidence. This data can be correlated with biochemical information such as defects in substrate binding kinetics, GTPase activities and interactions with the RAS effector RAF kinase.

AB - Cancers bearing the KRAS G13D mutation are notable for their distinct clinical behavior relative to other oncogenic KRAS mutations. We hypothesized that primary biochemical or biophysical properties of KRAS G13D might contribute to these clinical observations and as part of our study undertook structural studies using x-ray crystallography. In this data article we discuss several x-ray diffraction datasets that yielded structures of oncogenic KRAS mutants including a high resolution (1.13. Å) structure of KRAS G13D. The datasets are typical for high resolution x-ray diffraction data and allow the construction of atomic resolution, three dimensional structural models with high confidence. This data can be correlated with biochemical information such as defects in substrate binding kinetics, GTPase activities and interactions with the RAS effector RAF kinase.

KW - Cancer

KW - GTPase

KW - KRAS

KW - X-ray crystallography

UR - http://www.scopus.com/inward/record.url?scp=84945281671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945281671&partnerID=8YFLogxK

U2 - 10.1016/j.dib.2015.10.001

DO - 10.1016/j.dib.2015.10.001

M3 - Article

VL - 5

SP - 572

EP - 578

JO - Data in Brief

JF - Data in Brief

SN - 2352-3409

ER -